VC

Venkata Chalapathi Rao Makarla

Active Director Designated Partner DIN 08658337
DIN 08658337 First appointment Jan 2020 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkata Chalapathi Rao Makarla

Data last updated:

Venkata Chalapathi Rao Makarla is a Designated Partner at Ranik Biosciences Llp (since 2020). The company operates in Research & Development.

DIN 08658337
Primary Designation Designated Partner
Industry Research & Development
First Appointment 03 Jan 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner03 Jan 20202020Active

Board colleagues of Venkata Chalapathi Rao Makarla

NameDINCompanyDesignation
Gowri Neelima Makarla08658336Ranik Biosciences LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Ranik Biosciences Llp
Premium access

Shareholding and investment profile for Venkata Chalapathi Rao Makarla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkata Chalapathi Rao Makarla

Venkata Chalapathi Rao Makarla currently holds 1 directorship: Ranik Biosciences Llp (Designated Partner, since 03 Jan 2020).

Venkata Chalapathi Rao Makarla was first appointed on 03 Jan 2020 as Designated Partner at Ranik Biosciences Llp.

The current boards of Venkata Chalapathi Rao Makarla's companies include Gowri Neelima Makarla (Ranik Biosciences Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available